about
Current perspectives on the immunopathogenesis of systemic sclerosisUpdate on biomarkers in systemic sclerosis: tools for diagnosis and treatmentPrevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysisRenal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and managementAutoantibodies in systemic sclerosis: unanswered questionsPredictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortClinical and serological evaluation of a novel CENP-A peptide based ELISAA rare presentation of micro-angiopathic haemolytic anaemia in a critically ill patient: a case reportHeterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.Functional autoantibodies in systemic sclerosis pathogenesis.Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndromeMistaken identity: normotensive scleroderma renal crisis.Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.Systemic sclerosis and lupus: points in an interferon-mediated continuum.Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosisPrimary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patientsScleroderma lung diseaseSTAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertensionDetection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry.Association of the HLA-DRB1 with scleroderma in Chinese population.How should we treat vascular and fibrotic lung disease in scleroderma?Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosisScleroderma renal crisis: a pathology perspectivePredictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Genetics of scleroderma: implications for personalized medicine?Mortality in systemic sclerosis-a single centre study from the UK.Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects.Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.Antinuclear antibody-negative systemic sclerosis.
P2860
Q26741264-740E7168-D94F-48A1-8776-7BBD1FB3B179Q26995542-696B0490-25A1-46F3-B6AB-8F81D3E1BFFAQ27000819-3746D4C8-DDEA-4178-BF71-C74A2EEB1BF6Q27023769-CDB995C7-6602-4023-A94B-8A30E1F6DE5BQ28085026-12C863CD-B559-426C-AEE4-1BBBAFBE59ABQ28743863-B69F006B-03EF-4061-BABA-87C20D2A6242Q28750130-4FD830E0-1221-4B60-B4B2-ABA9EA809D32Q28751694-7CA81BC5-04BB-4B5C-9BB9-FFB6188F9E9FQ33293736-104CCFCD-E817-4FDA-BE16-6E57E6834D97Q33360501-DED400E4-1B75-4C0C-B417-952F4408C703Q33427917-93546F49-D696-4EC7-BD20-870C06402C99Q33691380-6EB04CC0-ABC9-43BD-8692-056BB67285F2Q33737250-DF2C1C41-922A-4B42-B3AF-9D926B8FCA56Q33886453-3A8A6F07-CE2F-4AF8-ACF1-222B905E9FE5Q33889629-5756EFBE-5D1B-4025-8AFD-02523130EB8DQ33899085-4F10B6DE-62B5-4CA3-AD8C-86095A144111Q33912324-9CB563D7-C4B0-496C-8CC6-8148F7887A3BQ33919119-C554BF7C-203F-4D31-97A7-8B56611227A0Q33929738-3F36255D-7625-4948-8C0F-D7CF6CC2DA76Q33956830-82D2C1B2-14FB-4DF0-8053-143BB1F05BAAQ33965859-3390D13F-056C-4052-B61F-717EC3AEB6B6Q34045145-05CFC916-6E1B-483E-89AB-80A73A33B1D3Q34128276-C7FF7C41-7F81-4FA7-AC18-1DC2E24B9023Q34129114-FB0A639F-3D6C-403E-B572-750C7B179E36Q34167350-05C8676E-0CCF-4EF0-AEBE-00A4F890DC72Q34186473-D3F85E05-6E1A-40AD-B063-D78D2CA581FEQ34218928-61E857B6-6EF4-44A7-B68D-7E06ED9B348CQ34346178-5F416E3B-0C08-49F9-9F06-B530B38911C7Q34375158-23D66A16-EBD0-49D3-A819-6481334B4210Q34545752-37BAE134-2A20-4933-8843-C8C3C57A45DAQ34653727-5AE54936-4794-47AF-98A8-DBD7143120F6Q35091575-E305E168-E302-4D61-9719-55016648F943Q35146164-AFD4659A-3448-4F4B-891A-3FB3B63F0541Q35309080-1244DDD8-8E6F-4A84-9FD4-AD945C144325Q35352582-E3BA618B-194B-4599-8125-32CC4E2FA2B7Q35503543-99CFC329-C432-4E3B-BCEA-028567482AA1Q35557818-D2071A1B-347C-4E9B-9ACA-7FDE151F5618Q35609106-2D791687-A791-4AEB-83FE-B6D72DDA514CQ35617650-00C37F68-39B7-4C09-8CC2-97B191D997AFQ35661256-613EB9BA-E758-4C93-95BE-048404D4F262
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Autoantibodies in systemic sclerosis.
@en
Autoantibodies in systemic sclerosis.
@nl
type
label
Autoantibodies in systemic sclerosis.
@en
Autoantibodies in systemic sclerosis.
@nl
prefLabel
Autoantibodies in systemic sclerosis.
@en
Autoantibodies in systemic sclerosis.
@nl
P1476
Autoantibodies in systemic sclerosis.
@en
P2093
Virginia D Steen
P356
10.1016/J.SEMARTHRIT.2005.03.005
P577
2005-08-01T00:00:00Z